@article{c3b202313deb42d4a31e44241f9c8d81,
title = "Issues of cancer care in people with mental disorders as perceived by cancer care providers: A quantitative questionnaire survey",
abstract = "Objectives: To reduce cancer care disparities, this study aimed to clarify the difficulties in cancer care for people with mental disorders as perceived by cancer care providers. Methods: Cancer care providers at 17 designated cancer hospitals in Japan were surveyed using mail questionnaires. Respondents were asked to rate 29 items related to difficulties or insufficiencies in cancer care for patients with mental disorders on a five-point Likert scale. We analyzed the proportion of respondents who answered “difficult/insufficient” in each item. We also calculated the proportions of responders stratified according to the presence of psychiatric support systems within their hospitals. Results: A total of 388 (58.4%) cancer care providers responded. Among the issues related to “difficulties in diagnosing and treating cancer,” support for decision-making, assessment of treatment adherence, and assessment of physical symptoms were perceived as most difficult (73.5%–81.5% of respondents). Among the issues related to {\textquoteleft}difficulties or insufficiencies in collaboration among multidisciplinary health care providers,{\textquoteright} the issue of advance consultation and sharing information with the patient's primary psychiatric care provider was perceived as most difficult (52.2%). Among the issues related to “insufficiencies of in-hospital and community medical systems,” education to provide reasonable accommodation was perceived as most insufficient (47.4%). The perceived difficulties of over half of the issues varied significantly between hospitals depending on the level of psychiatric support systems. Conclusions: This study clarified the difficulties of cancer care in patients with mental disorders as perceived by cancer care providers. Some issues may be resolved by psychiatric liaison teams.",
keywords = "cancer, diagnosis, health personnel, healthcare disparities, mental disorders, quantitative research, treatment",
author = "Yuto Yamada and Masaki Fujiwara and Tsuyoshi Etoh and Riho Wada and Shinichiro Inoue and Masafumi Kodama and Yusaku Yoshimura and Shigeo Horii and Takanori Matsushita and Maiko Fujimori and Taichi Shimazu and Naoki Nakaya and shiro Hinotsu and Masahiro Tabata and Kenji Tamura and Yosuke Uchitomi and Norihito Yamada and Masatoshi Inagaki",
note = "Funding Information: We thank all the hospitals and participants for their cooperation in the study. We would like to thank Shoko Yoshimoto and Sakura Hino for their logistic assistance. We also thank the late Dr. Masashi Kato for his guidance on the requirements for designated cancer hospitals in Japan. This work was funded by the Research for Promotion of Cancer Control Programs from the Japanese Ministry of Health, Labor and Welfare (MHLW) (H30‐Cancer Control‐general‐006 and 21EA1013). This work was also supported by the Japan Supportive, Palliative and Psychosocial Oncology Group (J‐SUPPORT), funded by the National Cancer Center Research and Development Fund (30A‐11), and the National Center Consortium in Implementation Science for Health Equity (N‐EQUITY), which is funded by the Japan Health Research Promotion Bureau (JH) Research Fund (2019‐(1)‐4). We thank Sarina Iwabuchi, PhD, from Edanz ( https://jp.edanz.com/ac ), for editing a draft of this manuscript. Funding Information: We thank all the hospitals and participants for their cooperation in the study. We would like to thank Shoko Yoshimoto and Sakura Hino for their logistic assistance. We also thank the late Dr. Masashi Kato for his guidance on the requirements for designated cancer hospitals in Japan. This work was funded by the Research for Promotion of Cancer Control Programs from the Japanese Ministry of Health, Labor and Welfare (MHLW) (H30-Cancer Control-general-006 and 21EA1013). This work was also supported by the Japan Supportive, Palliative and Psychosocial Oncology Group (J-SUPPORT), funded by the National Cancer Center Research and Development Fund (30A-11), and the National Center Consortium in Implementation Science for Health Equity (N-EQUITY), which is funded by the Japan Health Research Promotion Bureau (JH) Research Fund (2019-(1)-4). We thank Sarina Iwabuchi, PhD, from Edanz (https://jp.edanz.com/ac), for editing a draft of this manuscript. Funding Information: Yuto Yamada reports personal fees from Meiji and Sumitomo Dainippon outside the submitted work. Masaki Fujiwara holds grants from the Japanese Ministry of Health, Labour and Welfare (MHLW), received during the conduct of the study, and personal fees from Meiji outside the submitted work. Masafumi Kodama holds grants from the MHLW, received during the conduct of the study. Yusaku Yoshimura reports personal fees from Otsuka, Janssen, and Meiji outside the submitted work. Shinichiro Inoue reports personal fees from MSD, Eizai, Mochida, Ayumi, Pfizer, Chugai, Sumitomo Dainippon, and Yoshitomi outside the submitted work. Yosuke Uchitomi holds grants from the MHLW. Norihito Yamada holds grants from the MHLW, received during the conduct of the study, and personal fees from Chugai Igakusha and MSD outside the submitted work. Masatoshi Inagaki holds grants from the MHLW, received during the conduct of the study; personal fees from Technomics, Fuji Keizai, Novartis, Pfizer, MSD, Yoshitomiyakuhin, Meiji, Eisai, Otsuka, Sumitomo Dainippon, Mochida, Janssen, Takeda, and Eli Lilly; and grants from Otsuka, Eisai, Daiichi Sankyo, Pfizer, Astellas, MSD, Takeda, Fujifilm, Shionogi, and Mochida outside the submitted work. All other authors have nothing to disclose. Publisher Copyright: {\textcopyright} 2022 John Wiley & Sons Ltd.",
year = "2022",
month = sep,
doi = "10.1002/pon.5992",
language = "English",
volume = "31",
pages = "1572--1580",
journal = "Psycho-Oncology",
issn = "1057-9249",
publisher = "John Wiley and Sons Ltd",
number = "9",
}
